Trials / Sponsors / Prof. Dr. Richard F Schlenk
Prof. Dr. Richard F Schlenk
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment) | Phase 2 | 2020-07-17 |
| Recruiting | The Sarcoma Biology and Outcome Project Sarcoma, Malignant Mesenchymoma, Sarcoma of Bone and Connective Tissue | — | 2019-07-23 |